U.S. Microbiome Therapeutics Market Trends 2030: Advancements in Live Biotherapeutic Products and Microbiome-Based Drug Development
The US Microbiome Therapeutics Market is driven by growing research into microbiome-based therapies, increasing clinical trial activity, and rising interest in innovative treatments for gastrointestinal and other chronic conditions. Strong biotechnology investments and collaborations between pharmaceutical companies and research institutions are further contributing to market expansion...
0 Комментарии 0 Поделились 84 Просмотры 0 предпросмотр